We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Berdeja - Phase 1/2 Study of Oral MLN9708, A Novel, Investigational Proteasome Inhibitor, in Combination with Lenalidomide and Dexamethasone in Patients with Previously Untreated Multiple Myeloma (MM)
Jesus G. Berdeja, MD
Sarah Cannon Research Institute
Nashville, Tennessee, USA
12.01.11

Be the first to comment

 related articles